Nicorette Freshmint (Nicotine)

Nicotine, the active ingredient in Nicorette Freshmint, is a nicotine replacement therapy presented as an oromucosal formulation for oromucosal use. It is used to help adults who smoke to reduce nicotine withdrawal symptoms and cravings during a quit attempt.

GNH USA supplies Nicorette Freshmint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicorette Freshmint is a nicotine replacement product that supports smoking cessation and related nicotine‑dependence conditions. - Smoking cessation: helps reduce withdrawal symptoms and cravings in adults who are trying to quit smoking. - Tobacco dependence: provides a controlled nicotine source to ease transition away from cigarettes. - Nicotine addiction: assists individuals in managing physiological dependence on nicotine.

Nicorette Freshmint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or tingling - Throat soreness or dryness - Nausea or upset stomach - Hiccups - Headache - Dizziness

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Chest pain or palpitations - Irregular heartbeat - Severe oral ulceration - Persistent vomiting - Signs of nicotine toxicity (confusion, tremor).

When using Nicorette Freshmint, consider the following safety measures. - Assess nicotine dependence: evaluate the individual's smoking history before initiating therapy. - Cardiovascular risk: avoid use in patients with recent myocardial infarction or unstable angina. - Concomitant nicotine products: do not use with other nicotine replacement therapies simultaneously. - Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited. - Non‑smokers: product is not intended for individuals who have never smoked. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine can interact with several medications, altering their effects or increasing adverse risks.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase hypertensive response. - Certain antihypertensive agents (beta‑blockers, clonidine): nicotine may diminish blood‑pressure‑lowering effects. - Insulin or oral hypoglycemics: nicotine can affect glucose control. - Warfarin: potential alteration of anticoagulant effect. - Monoamine‑releasing agents (e.g., dextroamphetamine): increased cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Caffeine: nicotine may enhance stimulant effects. - Alcohol: combined use can increase dizziness or nausea. - Antidepressants (SSRIs, SNRIs): monitor for changes in mood or blood pressure. - Anticholinergic drugs: possible additive oral dryness. - Herbal supplements containing nicotine (e.g., certain teas).